Bus stop ads from the new UsAgainstAlzheimer's campaign include a QR code (pictured) that links to its advocacy website.

Alzheimer’s group amps pub­lic pres­sure with ad cam­paign as Medicare de­ci­sion looms

A new sev­en-fig­ure ad cam­paign takes aim – again – at Medicare’s pend­ing cov­er­age de­ci­sion on Alzheimer’s dis­ease an­ti-amy­loid drugs.

Us­Again­stAlzheimer’s launched the $1 mil­lion-plus na­tion­al ef­fort Sun­day, in­clud­ing a TV ad that ran across the the day’s morn­ing talk news shows. The group is the lat­est to push back on the Cen­ters for Medicare and Med­ic­aid Ser­vices’ pro­posed de­ci­sion to on­ly cov­er Bio­gen and Ei­sais’s Aduhelm and oth­er po­ten­tial an­ti-be­ta amy­loid drugs for pa­tients in clin­i­cal tri­als. CMS’ fi­nal de­ci­sion is set for re­lease on April 11.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.